Editas Medicine, Inc. (EDIT) Insider Trading

Name: Editas Medicine, Inc. (EDIT) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 9, 2026): Ory Daniel Scott (EVP, Chief Medical Officer): Grant/Award of 950,000 shares.

Get alerted when insiders trade EDIT

Email address

Loading company data...

Beta

Loading company details...

Beta